Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study. (24th March 2016)
- Record Type:
- Journal Article
- Title:
- Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study. (24th March 2016)
- Main Title:
- Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study
- Authors:
- Rouhani, Saba
Peñataro Yori, Pablo
Paredes Olortegui, Maribel
Siguas Salas, Mery
Rengifo Trigoso, Dixner
Mondal, Dinesh
Bodhidatta, Ladaporn
Platts-Mills, James
Samie, Amidou
Kabir, Furqan
Lima, Aldo
Babji, Sudhir
Mason, Carl J.
Kalam, Adil
Bessong, Pascal
Ahmed, Tahmeed
Mduma, Estomih
Bhutta, Zulfiqar A.
Lima, Ila
Ramdass, Rakhi
Lang, Dennis
George, Ajila
Zaidi, Anita K. M.
Kang, Gagandeep
Houpt, Eric
Kosek, Margaret N.
Olotegui, Maribel Paredes
Chavez, Cesar Banda
Trigoso, Dixner Rengifo
Flores, Julian Torres
Vasquez, Angel Orbe
Pinedo, Silvia Rengifo
Acosta, Angel Mendez
Ahmed, Imran
Alam, Didar
Ali, Asad
Bhutta, Zulfiqar A.
Qureshi, Shahida
Rasheed, Muneera
Soofi, Sajid
Turab, Ali
Yousafzai, Aisha K
Zaidi, Anita K. M.
Bodhidatta, Ladaporn
Mason, Carl J.
Babji, Sudhir
Bose, Anuradha
Jennifer, M. Steffi
John, Sushil
Kang, Gagandeep
Kaki, Shiny
Koshy, Beena
Muliyil, Jayaprakash
Raghava, Mohan Venkata
Ramachandran, Anup
Rose, Anuradha
Sharma, Srujan L.
Thomas, Rahul J.
Pan, William
Ambikapathi, Ramya
Carreon, Danny
Charu, Vivek
Dabo, Leyfou
Doan, Viyada
Graham, Jhanelle
Hoest, Christel
Knobler, Stacey
Lang, Dennis
McCormick, Benjamin
McGrath, Monica
Miller, Mark
Mohale, Archana
Nayyar, Gaurvika
Psaki, Stephanie
Rasmussen, Zeba
Richard, Stephanie A.
Seidman, Jessica C
Wang, Vivian
Blank, Rebecca
Gottlieb, Michael
Tountas, Karen H.
Amour, Caroline
Mduma, Estomih
Swema, Buliga Mujaga
Yarrot, Ladislaus
Nshama, Rosemary
Ahmed, Tahmeed
Ahmed, A. M. Shamsir
Tofail, Fahmida
Haque, Rashidul
Hossain, Iqbal
Islam, Munirul
Mahfuz, Mustafa
Mondal, Dinesh
Chandyo, Ram Krishna
Shrestha, Prakash Sunder
Shrestha, Rita
Ulak, Manjeswori
Black, Robert
Caulfield, Laura
Checkley, William
Chen, Ping
Kosek, Margaret
Lee, Gwenyth
Yori, Pablo Peñataro
Murray-Kolb, Laura E.
Schaefer, Barbara
Pendergast, Laura
Abreu, Cláudia
Havt, Alexandre
Costa, Hilda
Di Moura, Alessandra
Filho, Jose Quirino
Leite, Álvaro
Lima, Aldo
Lima, Noélia
Lima, Ila
Maciel, Bruna
Moraes, Milena
Mota, Francisco
Oriá, Reinaldo
Quetz, Josiane
Soares, Alberto
Patil, Crystal L
Bessong, Pascal
Mahopo, Cloupas
Maphula, Angelina
Nesamvuni, Cebisa
Nyathi, Emanuel
Samie, Amidou
Barrett, Leah
Gratz, Jean
Guerrant, Richard
Houpt, Eric
Petri, William
Scharf, Rebecca
Platts-Mills, James
Shrestha, Binob
Shrestha, Sanjaya Kumar
Strand, Tor
Svensen, Erling
… (more) - Abstract:
- Abstract : This longitudinal, multisite study reports a high prevalence of norovirus infection and norovirus-positive diarrhea and describes patterns of age acquisition, disease severity, genogroup-specific immunity, and relationships between norovirus and undernutrition in the first 2 years of life. Abstract: Background. Norovirus is an important cause of childhood diarrhea. We present data from a longitudinal, multicountry study describing norovirus epidemiology during the first 2 years of life. Methods. A birth cohort of 1457 children across 8 countries contributed 7077 diarrheal stools for norovirus testing. A subset of 199 children contributed additional asymptomatic samples (2307) and diarrheal stools (770), which were used to derive incidence rates and evaluate evidence for acquired immunity. Results. Across sites, 89% of children experienced at least 1 norovirus infection before 24 months, and 22.7% of all diarrheal stools were norovirus positive. Severity of norovirus-positive diarrhea was comparable to other enteropathogens, with the exception of rotavirus. Incidence of genogroup II (GII) infection was higher than genogroup I and peaked at 6–11 months across sites. Undernutrition was a risk factor for symptomatic norovirus infection, with an increase in 1 standard deviation of length-for-age z score associated with a 17% reduction (odds ratio, 0.83 [95% confidence interval, .72–.97]; P = .011) in the odds of experiencing diarrhea when norovirus was present,Abstract : This longitudinal, multisite study reports a high prevalence of norovirus infection and norovirus-positive diarrhea and describes patterns of age acquisition, disease severity, genogroup-specific immunity, and relationships between norovirus and undernutrition in the first 2 years of life. Abstract: Background. Norovirus is an important cause of childhood diarrhea. We present data from a longitudinal, multicountry study describing norovirus epidemiology during the first 2 years of life. Methods. A birth cohort of 1457 children across 8 countries contributed 7077 diarrheal stools for norovirus testing. A subset of 199 children contributed additional asymptomatic samples (2307) and diarrheal stools (770), which were used to derive incidence rates and evaluate evidence for acquired immunity. Results. Across sites, 89% of children experienced at least 1 norovirus infection before 24 months, and 22.7% of all diarrheal stools were norovirus positive. Severity of norovirus-positive diarrhea was comparable to other enteropathogens, with the exception of rotavirus. Incidence of genogroup II (GII) infection was higher than genogroup I and peaked at 6–11 months across sites. Undernutrition was a risk factor for symptomatic norovirus infection, with an increase in 1 standard deviation of length-for-age z score associated with a 17% reduction (odds ratio, 0.83 [95% confidence interval, .72–.97]; P = .011) in the odds of experiencing diarrhea when norovirus was present, after accounting for genogroup, rotavirus vaccine, and age. Evidence of acquired immunity was observed among GII infections only: Children with prior GII infection were found to have a 27% reduction in the hazard of subsequent infection (hazard ratio, 0.727; P = .010). Conclusions. The high prevalence of norovirus across 8 sites in highly variable epidemiologic settings and demonstration of protective immunity for GII infections provide support for investment in vaccine development. … (more)
- Is Part Of:
- Clinical infectious diseases. Volume 62:Number 10(2016)
- Journal:
- Clinical infectious diseases
- Issue:
- Volume 62:Number 10(2016)
- Issue Display:
- Volume 62, Issue 10 (2016)
- Year:
- 2016
- Volume:
- 62
- Issue:
- 10
- Issue Sort Value:
- 2016-0062-0010-0000
- Page Start:
- 1210
- Page End:
- 1217
- Publication Date:
- 2016-03-24
- Subjects:
- norovirus -- diarrhea -- immunity
Communicable diseases -- Periodicals
616.905 - Journal URLs:
- http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗ - DOI:
- 10.1093/cid/ciw072 ↗
- Languages:
- English
- ISSNs:
- 1058-4838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20870.xml